Brian Rowe
Corporate Officer/Principal presso ATEA PHARMACEUTICALS, INC.
Profilo
Brian Rowe is currently the Vice President of Business Development at Atea Pharmaceuticals, Inc. He previously worked as the Senior Director of Business Development at Radius Health, Inc. and as the Senior Director of Marketing Operations at Tesaro, Inc. Mr. Rowe completed his undergraduate degree at Bowdoin College and holds an MBA from The Wharton School of the University of Pennsylvania.
Posizioni attive di Brian Rowe
Società | Posizione | Inizio |
---|---|---|
ATEA PHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
Precedenti posizioni note di Brian Rowe
Società | Posizione | Fine |
---|---|---|
TESARO INC | Vendite & Marketing | - |
RADIUS HEALTH, INC. | Corporate Officer/Principal | - |
Formazione di Brian Rowe
Bowdoin College | Undergraduate Degree |
The Wharton School of the University of Pennsylvania | Masters Business Admin |
Esperienze
Posizioni ricoperte
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 1 |
---|---|
ATEA PHARMACEUTICALS, INC. | Health Technology |
Aziende private | 2 |
---|---|
Radius Health, Inc.
Radius Health, Inc. BiotechnologyHealth Technology Radius Health, Inc. is a biopharmaceutical company, which engages in developing and commercializing endocrine therapeutics in the areas of osteoporosis and oncology. The company’s lead product, Abaloparatide-SC, reduces fracture risk in postmenopausal women with osteoporosis. Its pipeline also includes the abaloparatide transdermal patch for potential use in osteoporosis, and RAD1901 for potential use in hormone-driven, or hormone-resistant, metastatic breast cancer, and vasomotor symptoms in postmenopausal women. The company was founded by John Katzenellenbogen, Stavros C. Manolagas, Michael Rosenblatt, and John T. Potts on October 3, 2003 and is headquartered in Boston, MA. | Health Technology |
Tesaro, Inc.
Tesaro, Inc. Pharmaceuticals: MajorHealth Technology TESARO, Inc. is an oncology-focused biopharmaceutical company, which engages in the research and development of biopharmaceutical products. The firm offers Niraparib products. The company was founded by Leon Oliver Moulder, Jr., Mary Lynne Hedley, and Richard J. Rodgers on March 26, 2010 and is headquartered in Waltham, MA. | Health Technology |
- Borsa valori
- Insiders
- Brian Rowe